Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Lumexa Imaging Holdings, Inc. Common Stock stock (LMRI) is currently trading at $11.06. Lumexa Imaging Holdings, Inc. Common Stock PS ratio (Price-to-Sales) is 1.04. Analyst consensus price target for LMRI is $22.71. WallStSmart rates LMRI as Sell.
- LMRI PE ratio analysis and historical PE chart
- LMRI PS ratio (Price-to-Sales) history and trend
- LMRI intrinsic value — DCF, Graham Number, EPV models
- LMRI stock price prediction 2025 2026 2027 2028 2029 2030
- LMRI fair value vs current price
- LMRI insider transactions and insider buying
- Is LMRI undervalued or overvalued?
- Lumexa Imaging Holdings, Inc. Common Stock financial analysis — revenue, earnings, cash flow
- LMRI Piotroski F-Score and Altman Z-Score
- LMRI analyst price target and Smart Rating
Lumexa Imaging Holdings, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) · 4 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales. Concerns around price/book and institutional own.. Significant fundamental concerns warrant caution or avoidance.
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Key Strengths (1)
Paying $1.04 for every $1 of annual revenue
Supporting Valuation Data
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Areas to Watch (3)
Very expensive at 6.3x book value
Very low institutional interest at 0.00%
Small-cap company with higher risk but more growth potential
Lumexa Imaging Holdings, Inc. Common Stock (LMRI) Detailed Analysis Report
Overall Assessment
This company scores 18/100 in our Smart Analysis, earning a F grade. Out of 4 metrics analyzed, 1 register as strengths (avg 8.0/10) while 3 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales. Valuation metrics including Price/Sales (1.04) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Price/Book, Institutional Own., Market Cap. Some valuation metrics including Price/Book (6.28) suggest expensive pricing.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Price/Book improves, as this is the primary drag on the overall score. Second, overall profitability trends. Third, top-line growth trajectory.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Price/Book and Institutional Own. are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
LMRI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
LMRI's Price-to-Sales ratio of 1.04x trades 22% below its historical average of 1.34x (0th percentile). The current valuation is 42% below its historical high of 1.79x set in Dec 2025, and 0% above its historical low of 1.04x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~1.8x as trailing revenue scaled faster than the stock price.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:22:24 AM
About Lumexa Imaging Holdings, Inc. Common Stock(LMRI)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company is headquartered in Raleigh, North Carolina.